Bailin Zhang

Guangzhou University of Chinese Medicine

Also affiliated with Nanjing Forestry University, Shanghai Jiao Tong University, Chinese Academy of Sciences, Harbin Institute of Technology, Shanghai Chest Hospital, Wuhan University, Buchang Pharma (China), Institute of Semiconductors

Biochemistry, Genetics and Molecular BiologyMedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease”.

Incremental biomarker and clinical outcomes after switch from enzyme therapy to eliglustat substrate reduction therapy in Gaucher disease

Molecular Genetics and Metabolism Reports(2021)10.1016/j.ymgmr.2021.100798

N/A

0DataRank · unranked

24 citations

Jiapeng Ruan, Audrey Ruan, Bailin Zhang, Vagishwari Murugesan, Haiqun Lin +4 more

Experimental strategies to improve drug-target identification in mass spectrometry-based thermal stability assays

Communications Chemistry(2023)10.1038/s42004-023-00861-1

N/A

0DataRank · unranked

14 citations

Konstantin Aizikov, Dmitry Grinfeld, Arne Kreutzmann, Daniel Mourad, Oliver Lange +6 more

Elucidating the susceptibility to breast cancer: an in-depth proteomic and transcriptomic investigation into novel potential plasma protein biomarkers

Frontiers in Molecular Biosciences(2024)10.3389/fmolb.2023.1340917

N/A

0DataRank · unranked

9 citations

Kexin Yi, Baoyue Chen, Bailin Zhang, Gao Jidong, Yang Wang